Development and biological evaluation of C60 fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent

Sheng Tung Huang, Chia Shin Ho, Chun Mao Lin, Hsu Wei Fang, Yi Xiang Peng

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Research studies in the field of C60 fullerene derivatives have significantly increased due to the broad range of biological activities that were found for these compounds. We designed and prepared a new C60 fullerene hybrid bearing thalidomide as a potential double-action anti-inflammatory agent, capable of simultaneous inhibition of LPS-induced NO and TNF-α production. The C60 fulleropyrrolidine-thalidomide dyad, CLT, was an effective agent to suppress the release of NO and TNF-α by the LPS-stimulated macrophages RAW 264.7. Ten micromolars of CLT effectively inhibited LPS-induced NO and TNF-α production by 47.3 ± 4.2% and 70.2 ± 4% with respected to the control, respectively. Furthermore, preliminary biochemical investigation revealed that CLT was a potent agent to suppress both LPS-induced intracellular ROS production and iNOS expression, and CLT also inhibited the phosphorylation of ERK which is an important protein kinase involved in the activation of TNF-α synthesis in LPS-activated macrophages. We believed that the studies herein would hold promise for future development of a new generation of potent anti-inflammatory agents.

Original languageEnglish
Pages (from-to)8619-8626
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number18
DOIs
Publication statusPublished - Sep 15 2008

Fingerprint

Thalidomide
Anti-Inflammatory Agents
Macrophages
Inflammation
Bearings (structural)
Protein Kinases
Action Potentials
Phosphorylation
Bioactivity
Chemical activation
Research
Derivatives
fullerene C60

Keywords

  • Anti-inflammation
  • C fulleropyrrolidine
  • Nitric oxide
  • Thalidomide
  • TNF-α

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Development and biological evaluation of C60 fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent. / Huang, Sheng Tung; Ho, Chia Shin; Lin, Chun Mao; Fang, Hsu Wei; Peng, Yi Xiang.

In: Bioorganic and Medicinal Chemistry, Vol. 16, No. 18, 15.09.2008, p. 8619-8626.

Research output: Contribution to journalArticle

@article{e3083857012d4f588cef9c57cf5238f2,
title = "Development and biological evaluation of C60 fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent",
abstract = "Research studies in the field of C60 fullerene derivatives have significantly increased due to the broad range of biological activities that were found for these compounds. We designed and prepared a new C60 fullerene hybrid bearing thalidomide as a potential double-action anti-inflammatory agent, capable of simultaneous inhibition of LPS-induced NO and TNF-α production. The C60 fulleropyrrolidine-thalidomide dyad, CLT, was an effective agent to suppress the release of NO and TNF-α by the LPS-stimulated macrophages RAW 264.7. Ten micromolars of CLT effectively inhibited LPS-induced NO and TNF-α production by 47.3 ± 4.2{\%} and 70.2 ± 4{\%} with respected to the control, respectively. Furthermore, preliminary biochemical investigation revealed that CLT was a potent agent to suppress both LPS-induced intracellular ROS production and iNOS expression, and CLT also inhibited the phosphorylation of ERK which is an important protein kinase involved in the activation of TNF-α synthesis in LPS-activated macrophages. We believed that the studies herein would hold promise for future development of a new generation of potent anti-inflammatory agents.",
keywords = "Anti-inflammation, C fulleropyrrolidine, Nitric oxide, Thalidomide, TNF-α",
author = "Huang, {Sheng Tung} and Ho, {Chia Shin} and Lin, {Chun Mao} and Fang, {Hsu Wei} and Peng, {Yi Xiang}",
year = "2008",
month = "9",
day = "15",
doi = "10.1016/j.bmc.2008.08.004",
language = "English",
volume = "16",
pages = "8619--8626",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "18",

}

TY - JOUR

T1 - Development and biological evaluation of C60 fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent

AU - Huang, Sheng Tung

AU - Ho, Chia Shin

AU - Lin, Chun Mao

AU - Fang, Hsu Wei

AU - Peng, Yi Xiang

PY - 2008/9/15

Y1 - 2008/9/15

N2 - Research studies in the field of C60 fullerene derivatives have significantly increased due to the broad range of biological activities that were found for these compounds. We designed and prepared a new C60 fullerene hybrid bearing thalidomide as a potential double-action anti-inflammatory agent, capable of simultaneous inhibition of LPS-induced NO and TNF-α production. The C60 fulleropyrrolidine-thalidomide dyad, CLT, was an effective agent to suppress the release of NO and TNF-α by the LPS-stimulated macrophages RAW 264.7. Ten micromolars of CLT effectively inhibited LPS-induced NO and TNF-α production by 47.3 ± 4.2% and 70.2 ± 4% with respected to the control, respectively. Furthermore, preliminary biochemical investigation revealed that CLT was a potent agent to suppress both LPS-induced intracellular ROS production and iNOS expression, and CLT also inhibited the phosphorylation of ERK which is an important protein kinase involved in the activation of TNF-α synthesis in LPS-activated macrophages. We believed that the studies herein would hold promise for future development of a new generation of potent anti-inflammatory agents.

AB - Research studies in the field of C60 fullerene derivatives have significantly increased due to the broad range of biological activities that were found for these compounds. We designed and prepared a new C60 fullerene hybrid bearing thalidomide as a potential double-action anti-inflammatory agent, capable of simultaneous inhibition of LPS-induced NO and TNF-α production. The C60 fulleropyrrolidine-thalidomide dyad, CLT, was an effective agent to suppress the release of NO and TNF-α by the LPS-stimulated macrophages RAW 264.7. Ten micromolars of CLT effectively inhibited LPS-induced NO and TNF-α production by 47.3 ± 4.2% and 70.2 ± 4% with respected to the control, respectively. Furthermore, preliminary biochemical investigation revealed that CLT was a potent agent to suppress both LPS-induced intracellular ROS production and iNOS expression, and CLT also inhibited the phosphorylation of ERK which is an important protein kinase involved in the activation of TNF-α synthesis in LPS-activated macrophages. We believed that the studies herein would hold promise for future development of a new generation of potent anti-inflammatory agents.

KW - Anti-inflammation

KW - C fulleropyrrolidine

KW - Nitric oxide

KW - Thalidomide

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=51349169729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349169729&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2008.08.004

DO - 10.1016/j.bmc.2008.08.004

M3 - Article

C2 - 18723357

AN - SCOPUS:51349169729

VL - 16

SP - 8619

EP - 8626

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 18

ER -